While a pronounced use-dependent sodium channel block in an erythromelalgia-causing NaV1.7 mutation has been demonstrated before (Choi et al., 2009), the mechanisms that lead to the observed analgesic effect are not fully understood. This evidence concerns the gene SCN9A and erythromelalgia.